AGL 5.50 Decreased By ▼ -0.10 (-1.79%)
ANL 8.69 Decreased By ▼ -0.21 (-2.36%)
AVN 75.84 Decreased By ▼ -1.14 (-1.48%)
BOP 5.18 Decreased By ▼ -0.07 (-1.33%)
CNERGY 4.51 Decreased By ▼ -0.14 (-3.01%)
EFERT 81.09 Decreased By ▼ -0.13 (-0.16%)
EPCL 50.00 Decreased By ▼ -0.03 (-0.06%)
FCCL 12.53 Decreased By ▼ -0.63 (-4.79%)
FFL 5.52 Decreased By ▼ -0.18 (-3.16%)
FLYNG 6.95 Decreased By ▼ -0.15 (-2.11%)
FNEL 4.65 Decreased By ▼ -0.11 (-2.31%)
GGGL 8.58 Decreased By ▼ -0.22 (-2.5%)
GGL 14.25 Decreased By ▼ -0.35 (-2.4%)
HUMNL 5.59 Decreased By ▼ -0.08 (-1.41%)
KEL 2.54 Decreased By ▼ -0.09 (-3.42%)
LOTCHEM 27.98 Decreased By ▼ -0.67 (-2.34%)
MLCF 23.70 Decreased By ▼ -0.99 (-4.01%)
OGDC 71.64 Decreased By ▼ -0.87 (-1.2%)
PAEL 15.09 Decreased By ▼ -0.28 (-1.82%)
PIBTL 4.89 Decreased By ▼ -0.09 (-1.81%)
PRL 15.81 Decreased By ▼ -0.39 (-2.41%)
SILK 1.07 No Change ▼ 0.00 (0%)
TELE 8.94 Decreased By ▼ -0.26 (-2.83%)
TPL 7.03 Decreased By ▼ -0.22 (-3.03%)
TPLP 18.31 Decreased By ▼ -0.39 (-2.09%)
TREET 21.03 Decreased By ▼ -0.67 (-3.09%)
TRG 134.55 Decreased By ▼ -2.00 (-1.46%)
UNITY 16.63 Decreased By ▼ -0.39 (-2.29%)
WAVES 9.32 Decreased By ▼ -0.57 (-5.76%)
WTL 1.36 Decreased By ▼ -0.05 (-3.55%)
BR100 4,154 Decreased By -71 (-1.68%)
BR30 15,289 Decreased By -229.2 (-1.48%)
KSE100 41,613 Decreased By -537.4 (-1.28%)
KSE30 15,360 Decreased By -228.1 (-1.46%)
World

EU agency finds no specific age risk for AstraZeneca so far

  • Germany on Tuesday became the latest in a series of countries to advise against using the AstraZeneca jab for younger people after rare reports of clotting.
Published March 31, 2021
Follow us

THE HAGUE: Experts probing links between the AstraZeneca coronavirus vaccine and blood clots have found no specific risk factors, including age, but are carrying out further analysis, the EU's drug regulator said Wednesday.

The European Medicines Agency (EMA) said however that its safety committee expected to issue an "updated recommendation" on the controversial vaccine after its monthly meeting next week.

Germany on Tuesday became the latest in a series of countries to advise against using the AstraZeneca jab for younger people after rare reports of clotting, despite the EMA saying it is safe.

"At present the review has not identified any specific risk factors, such as age, gender or a previous medical history of clotting disorders, for these very rare events," the Amsterdam-based EMA said in a statement.

"A causal link with the vaccine is not proven, but is possible and further analysis is continuing."

The EMA statement came after experts met on Monday to discuss their latest findings on the AstraZeneca vaccine. Their comments will be discussed at the safety committee's meeting next week.

The watchdog reiterated the view it gave in a keenly-anticipated statement on March 18, saying "its benefits in protecting people from Covid-19 with the associated risks of death and hospitalisation outweigh the possible risks."

Comments

Comments are closed.

EU agency finds no specific age risk for AstraZeneca so far

ECC approves wheat import of 450,000MT from Russia

Time to 'say no' to cartels, says PM, as energy bill touches $27bn

Rupee drops 0.10% against US dollar

UAE, Ukraine to start talks on bilateral trade deal

Oil prices rise after OPEC+ keeps output steady, Russian price cap imposed

Taliban acting defence minister holds talks with UAE president

Cotton arrival falls 40% year-on-year

Engro Corp to pursue potential investment opportunity in tower infrastructure sector

Big tax defaulters: FBR to auction off properties, trademarks

FBR set to fix minimum value for sugar supply